Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
Chapter 5: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
Chapter 6: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
Chapter 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
Chapter 8: COMPANY PROFILES
8.1. Abbott
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Ascensia Diabetes Care
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Roche
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. LifeScan
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Medtronic
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Terumo Corporation
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Bayer AG
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Arkray
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Accu-Chek
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Trividia Health
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ABBOTT: NET SALES, 2020-2022*?($MILLION)
FIGURE 21. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ASCENSIA DIABETES CARE: NET SALES, 2020-2022*?($MILLION)
FIGURE 24. ASCENSIA DIABETES CARE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ASCENSIA DIABETES CARE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. ROCHE: NET SALES, 2020-2022*?($MILLION)
FIGURE 27. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. LIFESCAN: NET SALES, 2020-2022*?($MILLION)
FIGURE 30. LIFESCAN: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. LIFESCAN: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. MEDTRONIC: NET SALES, 2020-2022*?($MILLION)
FIGURE 33. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. TERUMO CORPORATION: NET SALES, 2020-2022*?($MILLION)
FIGURE 36. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. TERUMO CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. BAYER AG: NET SALES, 2020-2022*?($MILLION)
FIGURE 39. BAYER AG: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. BAYER AG: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. ARKRAY: NET SALES, 2020-2022*?($MILLION)
FIGURE 42. ARKRAY: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. ARKRAY: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. ACCU-CHEK: NET SALES, 2020-2022*?($MILLION)
FIGURE 45. ACCU-CHEK: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. ACCU-CHEK: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. TRIVIDIA HEALTH: NET SALES, 2020-2022*?($MILLION)
FIGURE 48. TRIVIDIA HEALTH: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. TRIVIDIA HEALTH: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ABBOTT: KEY EXECUTIVES
TABLE 05. ABBOTT: COMPANY SNAPSHOT
TABLE 06. ABBOTT: OPERATING SEGMENTS
TABLE 07. ABBOTT: PRODUCT PORTFOLIO
TABLE 08. ABBOTT: KEY STRATERGIES
TABLE 09. ASCENSIA DIABETES CARE: KEY EXECUTIVES
TABLE 10. ASCENSIA DIABETES CARE: COMPANY SNAPSHOT
TABLE 11. ASCENSIA DIABETES CARE: OPERATING SEGMENTS
TABLE 12. ASCENSIA DIABETES CARE: PRODUCT PORTFOLIO
TABLE 13. ASCENSIA DIABETES CARE: KEY STRATERGIES
TABLE 14. ROCHE: KEY EXECUTIVES
TABLE 15. ROCHE: COMPANY SNAPSHOT
TABLE 16. ROCHE: OPERATING SEGMENTS
TABLE 17. ROCHE: PRODUCT PORTFOLIO
TABLE 18. ROCHE: KEY STRATERGIES
TABLE 19. LIFESCAN: KEY EXECUTIVES
TABLE 20. LIFESCAN: COMPANY SNAPSHOT
TABLE 21. LIFESCAN: OPERATING SEGMENTS
TABLE 22. LIFESCAN: PRODUCT PORTFOLIO
TABLE 23. LIFESCAN: KEY STRATERGIES
TABLE 24. MEDTRONIC: KEY EXECUTIVES
TABLE 25. MEDTRONIC: COMPANY SNAPSHOT
TABLE 26. MEDTRONIC: OPERATING SEGMENTS
TABLE 27. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 28. MEDTRONIC: KEY STRATERGIES
TABLE 29. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 30. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 31. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 32. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 33. TERUMO CORPORATION: KEY STRATERGIES
TABLE 34. BAYER AG: KEY EXECUTIVES
TABLE 35. BAYER AG: COMPANY SNAPSHOT
TABLE 36. BAYER AG: OPERATING SEGMENTS
TABLE 37. BAYER AG: PRODUCT PORTFOLIO
TABLE 38. BAYER AG: KEY STRATERGIES
TABLE 39. ARKRAY: KEY EXECUTIVES
TABLE 40. ARKRAY: COMPANY SNAPSHOT
TABLE 41. ARKRAY: OPERATING SEGMENTS
TABLE 42. ARKRAY: PRODUCT PORTFOLIO
TABLE 43. ARKRAY: KEY STRATERGIES
TABLE 44. ACCU-CHEK: KEY EXECUTIVES
TABLE 45. ACCU-CHEK: COMPANY SNAPSHOT
TABLE 46. ACCU-CHEK: OPERATING SEGMENTS
TABLE 47. ACCU-CHEK: PRODUCT PORTFOLIO
TABLE 48. ACCU-CHEK: KEY STRATERGIES
TABLE 49. TRIVIDIA HEALTH: KEY EXECUTIVES
TABLE 50. TRIVIDIA HEALTH: COMPANY SNAPSHOT
TABLE 51. TRIVIDIA HEALTH: OPERATING SEGMENTS
TABLE 52. TRIVIDIA HEALTH: PRODUCT PORTFOLIO
TABLE 53. TRIVIDIA HEALTH: KEY STRATERGIES